Dyax's P2P Acquisition

Dyax raised a round of funding on January 22, 2016. Investors include Shire.

Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company utilizes its proprietary drug discovery technology to…

Articles about Dyax's P2P Acquisition: